ELTP ELITE PHARMACEUTICALS INC
FollowCommon Stock (common), issuer CIK 1053369
Filings received so far for Q3 2026: 0 13F filers report a position in ELTP shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Dash Barry Hdirector | 2026-10-09 | +100,000 P | $0.2598 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|
Events
LaRocca John reported holdings of ELTP shares in a Form 3 filed 2026-11-06. 0001732197-26-000004
Accepted , ingestedDash Barry H bought 100,000 ELTP shares on 2026-10-09, Form 4 filed 2026-10-19. 0001493152-26-047486
Accepted , ingested